Control of Blood Glucose & Insulin

Control of Blood Glucose

Introduction

The lecture discusses the critical importance of blood glucose control, emphasizing its relevance in both human and veterinary medicine, particularly in the context of diabetes. Diabetes, a prevalent endocrine disease in animals, mirrors the human epidemic, necessitating a thorough understanding of glucose metabolism. The lecture aims to elucidate the hormonal mechanisms regulating glucose metabolism, which are crucial for effective therapeutic intervention and management of diabetic conditions.

The Discovery of Insulin

The pivotal experiment conducted by Banting and Best, which involved the surgical removal of the pancreas from a dog, demonstrated the pancreas's indispensable role in glucose regulation. The resultant diabetes-like symptoms observed post-pancreatectomy were reversed upon injecting minced pancreatic extract, underscoring the presence of an active, glucose-regulating substance within the pancreas. This groundbreaking work led to the isolation and purification of insulin through meticulous tissue extraction, separation techniques, and activity-based assays. In 1922, Leonard Thompson, a 14-year-old boy suffering from diabetes, became the first recipient of an insulin injection, marking a watershed moment in the treatment of diabetes and transforming it from a fatal condition to a manageable one.

The Pancreas and Islets of Langerhans

The pancreas, an organ situated in close proximity to the stomach, spleen, and duodenum, harbors the islets of Langerhans—the endocrine component dedicated to hormone secretion. Histological examination of the pancreas reveals these islets as distinct, highly vascularized clusters of cells, facilitating the direct release of hormones into the bloodstream for systemic distribution. These hormones play a crucial role in maintaining metabolic homeostasis.

Cell Types within Islets

Alpha Cells: These cells are responsible for the synthesis and secretion of glucagon, a hormone that elevates blood glucose levels by promoting glycogenolysis and gluconeogenesis in the liver.
Beta Cells: Beta cells synthesize and secrete insulin, the primary hormone responsible for lowering blood glucose levels. They constitute the most abundant cell type within the islets of Langerhans.
Delta Cells: Delta cells secrete somatostatin, a regulatory peptide that inhibits the secretion of several other hormones, including insulin, glucagon, and growth hormone. Somatostatin plays a role in modulating endocrine function and nutrient absorption.
Other Cells: In addition to the aforementioned cell types, the islets of Langerhans also contain other cell populations, such as PP cells that secrete pancreatic polypeptide, which influences gastrointestinal function and appetite.

The differentiation of these distinct cell types within the islets of Langerhans is orchestrated by specific transcription factors, which govern gene expression and determine cellular identity. Immunofluorescence techniques, which employ fluorescently labeled antibodies, are utilized to visualize and distinguish these cell types based on their unique hormonal products. For example, insulin can be visualized in red, somatostatin in blue, and glucagon in green using specific antibodies.

Glucose Homeostasis

The maintenance of blood glucose within a narrow physiological range is paramount as it ensures a constant supply of energy to tissues while preventing the detrimental effects of hyperglycemia or hypoglycemia. Tissues such as the nervous system, retina, astrocytes, and gonadal epithelium rely almost exclusively on glucose for their metabolic needs. Therefore, precise regulation of blood glucose levels is crucial for their normal function.

Sources of Glucose

Dietary Carbohydrates: Following a meal, dietary carbohydrates are digested and absorbed into the bloodstream, leading to a transient increase in blood glucose levels. This influx of glucose is a primary stimulus for insulin secretion.
Glycogenolysis: Glycogen, a branched polymer of glucose, is stored primarily in the liver and muscle tissue. During periods of fasting or increased energy demand, glycogenolysis—the breakdown of glycogen—releases glucose into the bloodstream to maintain blood glucose levels.
Gluconeogenesis: Gluconeogenesis is the de novo synthesis of glucose from non-carbohydrate precursors, such as amino acids and fatty acids, primarily in the liver. This process is particularly important during prolonged fasting or starvation, as it provides a sustained source of glucose when dietary intake is limited.

Insulin: The Hypoglycemic Hormone

Insulin, secreted by the beta cells of the pancreatic islets of Langerhans, stands as the sole hormone capable of lowering blood glucose levels, making it a pivotal regulator of glucose metabolism. Its secretion is indicative of a transition from a fasting to a postprandial state, signaling the body to store excess glucose and utilize it for energy production.

Insulin Synthesis and Secretion

Insulin is synthesized via a complex pathway that involves the sequential processing of a pre-prohormone. Initially, preproinsulin is synthesized in the rough endoplasmic reticulum of beta cells. Following the removal of the signal peptide, proinsulin is formed, which undergoes further folding and disulfide bond formation. Proinsulin is then cleaved by specific endopeptidases, resulting in the formation of active insulin and C-peptide. Both insulin and C-peptide are stored within secretory granules in beta cells, complexed with zinc ions to form crystalline structures. Upon stimulation, these granules are released via exocytosis in response to elevated glucose levels. The release of pre-formed insulin is followed by de novo synthesis to replenish the cellular stores. Insulin has a remarkably short half-life of approximately 6 minutes due to its rapid metabolism in the liver, whereas C-peptide exhibits a longer half-life, making it a useful marker of insulin secretion.

Stimuli for Insulin Secretion

Glucose serves as the primary stimulus for insulin secretion. The entry of glucose into beta cells is facilitated by GLUT transporters, specifically GLUT2 in humans and other species. Once inside the beta cell, glucose is metabolized via glycolysis, leading to an increase in the ATP/ADP ratio. This increase in ATP levels causes the ATP-sensitive potassium channels ( $K_{ATP}$ channels) to close, resulting in depolarization of the beta cell membrane. Depolarization triggers the opening of voltage-gated calcium channels, leading to an influx of calcium ions into the cell. The increase in intracellular calcium concentration triggers the fusion of insulin-containing secretory granules with the plasma membrane, resulting in the release of insulin into the bloodstream. In addition to glucose, gastrointestinal hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), as well as autonomic neurotransmitters, also modulate insulin secretion.

Actions of Insulin

Insulin exerts a multitude of effects on glucose metabolism and energy storage, promoting:

Glycogen Synthesis: Insulin stimulates the activity of glycogen synthase, the enzyme responsible for catalyzing the addition of glucose molecules to glycogen chains, thereby promoting the storage of glucose as glycogen in the liver and muscle.
Glucose Uptake in Muscle and Adipose Tissue: Insulin promotes the translocation of GLUT4 glucose transporters to the plasma membrane of muscle and adipose cells, facilitating the uptake of glucose from the bloodstream into these tissues.
Fatty Acid Synthesis in Adipose Tissue: Insulin enhances the activity of enzymes involved in fatty acid synthesis, leading to the conversion of excess glucose into fatty acids, which are then stored as triglycerides in adipose tissue.

Conversely, insulin inhibits:

Gluconeogenesis: Insulin suppresses the expression of key enzymes involved in gluconeogenesis in the liver, reducing the production of glucose from non-carbohydrate precursors.
Protein Catabolism: Insulin reduces protein breakdown and promotes protein synthesis, contributing to a positive nitrogen balance and the maintenance of muscle mass.
Lipolysis: Insulin inhibits the activity of hormone-sensitive lipase, the enzyme responsible for breaking down triglycerides into fatty acids and glycerol, thereby reducing the release of fatty acids from adipose tissue.

In addition to its effects on glucose, lipid, and protein metabolism, insulin also reduces glucagon secretion from alpha cells and promotes the relaxation of smooth muscle in blood vessels, contributing to vasodilation and increased blood flow.

Insulin Signaling Pathway

Insulin initiates its cellular effects by binding to the insulin receptor, a receptor tyrosine kinase located on the plasma membrane of target cells. Ligand binding induces autophosphorylation of the receptor, leading to the recruitment and phosphorylation of intracellular substrate IRS proteins. Phosphorylated IRS proteins then activate downstream signaling cascades, including the PI3K/Akt pathway, which plays a central role in mediating the metabolic effects of insulin. Activation of AKT/PKB leads to the regulation of glucose transport, protein synthesis, glycogen synthesis, and other metabolic processes.

Glucose Transporters (GLUTs)

Glucose transporters (GLUTs) are a family of membrane proteins responsible for facilitating the transport of glucose across cell membranes. Different tissues express different GLUT isoforms, each with distinct kinetic properties and regulatory mechanisms. GLUT4, found predominantly in skeletal muscle and adipose tissue, is insulin-sensitive and translocates to the plasma membrane upon insulin stimulation, thereby increasing glucose uptake into these tissues.

Regulation of GLUT4

The translocation of GLUT4-containing vesicles to the plasma membrane is a key regulatory step in insulin-stimulated glucose uptake. This process involves the activation of signaling pathways, including the PI3K/Akt pathway, which promotes the fusion of GLUT4-containing vesicles with the plasma membrane, resulting in an increase in the number of GLUT4 transporters on the cell surface.

Post-Translational Regulation by Insulin

Insulin also regulates metabolic enzyme activity post-translationally, modulating the activity of enzymes involved in glucose metabolism through phosphorylation or dephosphorylation events. For example, insulin promotes the phosphorylation and activation of glucokinase and glycogen synthase, while simultaneously inactivating glycogen phosphorylase, thereby maximizing glucose storage as glycogen. In adipose tissue, insulin activates lipoprotein lipase, an enzyme that hydrolyzes triglycerides in lipoproteins, promoting the uptake of fatty acids into adipocytes for storage.